Astellas Pharma Inc.

Global Japanese drugmaker Astellas Pharma, founded 1923, drives growth with oncology and specialty products like XTANDI, XOSPATA, PADCEV, and VEOZAH, backed by R&D partnerships with Roche, Harvard, and Merck.

Headquarters: Japan (JPN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 13,643
HQ: Chuo

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
4503	Astellas Pharma Inc. Cap: 4051.7B \| P/E: 32.6	EQUITY	JPX	JPY	JP3942400007	Active	📈